Cargando…

Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study

BACKGROUND: Some oral antihyperglycemic agents may increase risk of hypoglycemia and thereby reduce patient quality of life. Our objective was to assess the impact of the severity and frequency of self-reported hypoglycemia on health-related quality of life (HRQoL) among patients with type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrett, Elizabeth, Radican, Larry, Davies, Michael J, Zhang, Qiaoyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148563/ https://www.ncbi.nlm.nih.gov/pubmed/21777428 http://dx.doi.org/10.1186/1756-0500-4-251

Ejemplares similares

Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study
por: Zhang, Qiaoyi, et al.
Publicado: (2011)

Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Marrett, Elizabeth, et al.
Publicado: (2012)

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
por: Hauber, A. Brett, et al.
Publicado: (2015)

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes
por: Tunceli, Kaan, et al.
Publicado: (2015)

Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia
por: Baretić, Maja, et al.
Publicado: (2020)

Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013
por: Clemens, Kristin K., et al.
Publicado: (2015)

Burden of peripheral arterial disease in Europe and the United States: a patient survey
por: Marrett, Elizabeth, et al.
Publicado: (2013)

Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2010)

Frequency and Predictors of Self-Reported Hypoglycemia in Insulin-Treated Diabetes
por: Malkani, Samir, et al.
Publicado: (2017)

Impact of Hypoglycemia Associated With Antihyperglycemic Medications on Vascular Risks in Veterans With Type 2 Diabetes
por: Zhao, Yingnan, et al.
Publicado: (2012)

Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
por: Balijepalli, Chakrapani, et al.
Publicado: (2017)

Tropical Plant Extracts as Potential Antihyperglycemic Agents
por: Manaharan, Thamilvaani, et al.
Publicado: (2012)

Antihyperglycemic and hypolipidemic activity of methanolic extract of Amaranthus viridis leaves in experimental diabetes
por: Krishnamurthy, Girija, et al.
Publicado: (2011)

Antihyperglycemic Activity of Various Fractions of Cassia auriculata Linn. in Alloxan Diabetic Rats
por: Surana, S. J., et al.
Publicado: (2008)

Proximal Predictors of Long-Term Discontinuance with Noninsulin Antihyperglycemic Agents
por: Stuart, Bruce C., et al.
Publicado: (2016)

An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with Metformin
por: Traina, Shana B., et al.
Publicado: (2017)

Amla as an antihyperglycemic and hepato-renal protective agent in fluoride induced toxicity
por: Vasant, Rupal A., et al.
Publicado: (2012)

Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
por: Suaifan, Ghadeer A. R. Y., et al.
Publicado: (2015)

Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice
por: Santos, Flávia Almeida, et al.
Publicado: (2012)

Antihyperglycemic, antihyperlipidemic and hepatoprotective effects of Ficus ottoniifolia (Miq.) Miq. supplementation in alloxan-induced diabetic rats
por: Aloke, Chinyere, et al.
Publicado: (2021)

Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study
por: Bailey, Timothy S., et al.
Publicado: (2021)

Metabolic effects of antihyperglycemic agents and mortality: meta-analysis of randomized controlled trials
por: Rados, Dimitris Varvaki, et al.
Publicado: (2020)

Selecting antihyperglycemic agents with proven safety: A must in COVID-19 era
por: Ghosal, Samit
Publicado: (2020)

The unexpected truth about dates and hypoglycemia
por: Yasawy, Mohammed I.
Publicado: (2016)

Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents
por: Abe, Hironori, et al.
Publicado: (2019)

Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
por: Munshi, Medha N., et al.
Publicado: (2022)

Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease
por: Chang, Po-Ya, et al.
Publicado: (2015)

Survey on hypoglycemia among insulin-treated patients with diabetes: The Colombian International Operations Hypoglycemia Assessment Tool population
por: Gómez, Ana M., et al.
Publicado: (2019)

Hypoglycemia: When to Treat?
por: Kallem, Venkat Reddy, et al.
Publicado: (2017)

Antihyperglycemic Medications and Cardiovascular Risk Reduction
por: Anderson, Sarah L, et al.
Publicado: (2017)

Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization
por: Montejano, Leslie, et al.
Publicado: (2015)

Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes
por: Qiu, Rong, et al.
Publicado: (2016)

Adherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005–2008
por: Gentil, Lia, et al.
Publicado: (2015)

Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes
por: Guzauskas, Gregory F, et al.
Publicado: (2021)

Self-reported frequency, severity of, and awareness of hypoglycemia in type 2 diabetes patients in Turkey
por: Büyükkaya Besen, Dilek, et al.
Publicado: (2016)

Self-Treated Hypoglycemia in Type 2 Diabetes Mellitus: Results from the Second Wave of an International Cross-Sectional Survey
por: Brod, Meryl, et al.
Publicado: (2016)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Kushner, Pamela
Publicado: (2010)

Frequency and Severity of Adverse Drug Reactions Due to Self-Medication: A Cross-Sectional Multicentre Survey in Emergency Departments
por: Asseray, Nathalie, et al.
Publicado: (2013)

Characteristics of Elderly Patients Initiating Sitagliptin or Non-DPP-4-Inhibitor Oral Antihyperglycemic Agents: Analysis of a Cross-Sectional US Claims Database
por: Wang, Tongtong, et al.
Publicado: (2018)

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes
por: Hauber, A Brett, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_klk69f97a5kkndsupj3vbqmqsf